DK3445344T3 - Nikotinadministrationsprodukt, relaterede anvendelser og orale doseringsformer, samt fremgangsmåder til fremstilling - Google Patents

Nikotinadministrationsprodukt, relaterede anvendelser og orale doseringsformer, samt fremgangsmåder til fremstilling Download PDF

Info

Publication number
DK3445344T3
DK3445344T3 DK16717648.6T DK16717648T DK3445344T3 DK 3445344 T3 DK3445344 T3 DK 3445344T3 DK 16717648 T DK16717648 T DK 16717648T DK 3445344 T3 DK3445344 T3 DK 3445344T3
Authority
DK
Denmark
Prior art keywords
nicotine
oral dosage
manufacturing methods
related uses
administrative
Prior art date
Application number
DK16717648.6T
Other languages
English (en)
Inventor
Jesper Thorsen
Jesper Neergaard
Birgitte Kringelum Breindal
Bjarne Vestbö
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55802381&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3445344(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Application granted granted Critical
Publication of DK3445344T3 publication Critical patent/DK3445344T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
DK16717648.6T 2016-04-21 2016-04-21 Nikotinadministrationsprodukt, relaterede anvendelser og orale doseringsformer, samt fremgangsmåder til fremstilling DK3445344T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2016/058925 WO2017182084A1 (en) 2016-04-21 2016-04-21 Nicotine delivery product, related uses and oral dosage forms, and methods of production

Publications (1)

Publication Number Publication Date
DK3445344T3 true DK3445344T3 (da) 2020-11-23

Family

ID=55802381

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16717648.6T DK3445344T3 (da) 2016-04-21 2016-04-21 Nikotinadministrationsprodukt, relaterede anvendelser og orale doseringsformer, samt fremgangsmåder til fremstilling

Country Status (5)

Country Link
US (1) US11311623B2 (da)
EP (1) EP3445344B1 (da)
DK (1) DK3445344T3 (da)
ES (1) ES2814296T3 (da)
WO (1) WO2017182084A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023053060A1 (en) * 2021-09-30 2023-04-06 Nicoventures Trading Limited Oral gum composition
WO2023110984A1 (en) 2021-12-16 2023-06-22 Philip Morris Products S.A. Novel hollow oral nicotine product
WO2023152119A1 (en) 2022-02-09 2023-08-17 Philip Morris Products S.A. Oral nicotine product with chewable carrier element

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3957698A (en) 1974-11-05 1976-05-18 The Dow Chemical Company Thermally reversible, amphoteric ion exchange resins consisting of crosslinked microbeads embedded in crosslinked matrix of opposite exchange group type
AU1031500A (en) 1998-11-03 2000-05-22 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
US6607752B2 (en) 2000-07-27 2003-08-19 Rohm And Haas Company Method for the anhydrous loading of nicotine onto ion exchange resins
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
US6586449B1 (en) 2002-05-28 2003-07-01 Cambrex Charles City, Inc. Nicotine-containing, controlled release composition and method
CA2513099A1 (en) 2003-02-04 2004-08-19 Gumlink A/S Compressed chewing gum tablet
EP1696923B1 (en) 2003-12-02 2009-08-19 Fertin Pharma A/S Nicotine delivery product and method for producing
ATE448786T1 (de) 2005-06-01 2009-12-15 Fertin Pharma As Verfahren zur herstellung eines nikotinzuführenden produkts
DK2018160T3 (da) 2006-03-16 2012-02-06 Tris Pharma Inc Modificeret depotformuleringer indeholdende lægemiddel-ionbytterharpikskomplekser
US20080286340A1 (en) 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
WO2009080022A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum tablet
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
AR071850A1 (es) 2008-05-21 2010-07-21 Novartis Ag Gomas de mascar en forma de tableta
CN102046021A (zh) 2008-05-26 2011-05-04 费尔廷制药公司 膜包衣压缩口香糖
CA2736531C (en) * 2008-09-17 2016-10-25 Niconovum Ab Process for preparing snuff composition
DK2177213T3 (da) 2008-09-17 2013-02-11 Siegfried Ltd Nicotine-containing granulate
US8506936B2 (en) 2008-11-25 2013-08-13 Watson Laboratories, Inc. Stabilized nicotine chewing gum
US20100247586A1 (en) 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
US20110070286A1 (en) 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
WO2011150959A1 (en) 2010-05-31 2011-12-08 Fertin Pharma A/S Formulation comprising nicotine and a cation exchange resin
ES2610152T3 (es) 2010-05-31 2017-04-26 Fertin Pharma A/S Formulación que comprende nicotina y una resina de intercambio catiónico
SE536491C2 (sv) * 2012-03-26 2013-12-27 Bionicotine Ab Påse innehållande nikotin och en tuggummikomposition

Also Published As

Publication number Publication date
ES2814296T3 (es) 2021-03-26
EP3445344A1 (en) 2019-02-27
US20190134207A1 (en) 2019-05-09
EP3445344B1 (en) 2020-08-19
US11311623B2 (en) 2022-04-26
WO2017182084A1 (en) 2017-10-26

Similar Documents

Publication Publication Date Title
DK3355884T3 (da) Tetrahydro-1h-pyrido[3,4-b]indol-antiøstrogenlægemidler
HK1255566A1 (zh) 氧代吡啶酰胺類衍生物、其製備方法及其在醫藥上的應用
DK3009511T3 (da) Hidtil ukendte crispr-enzymer og systemer
DK3354282T3 (da) Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
DK3139979T3 (da) Enhed, forstøver og fremgangsmåde
DK3328467T3 (da) Sensor, patron og lægemiddeladministrationsanordning
DK3174874T3 (da) Berberinsalte, ursodeoxycholsalte og kombinationer, fremgangsmåder til fremstilling og anvendelse deraf.
DK3408326T3 (da) Elastomerartikler, sammensætninger og fremgangsmåder til fremstilling deraf
IL262824A (en) Method, array and their uses
DK3229816T3 (en) Proton-bindende polymerer til oral administration
GB201516801D0 (en) Method, array and use thereof
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
DK3612579T3 (da) Pultrudat, fremstilling og anvendelse heraf
DK3268374T3 (da) Kv1.3-inhibitorer og deres medicinske anvendelse
IL261643B (en) Piperidine derivatives, their preparation and use
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
IL261368A (en) Novel prna three-way junctions
PL3157901T3 (pl) Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
EP3402438A4 (en) ORAL DEVICE
DK3383397T3 (da) Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin
DK3394045T3 (da) Co-krystal, fremstillingsfremgangsmåde deraf og medikament som indeholder co-krystal.
DK3157506T3 (da) Smagsmaskeret oral, farmaceutisk sammensætning
DK3436120T3 (da) Oral medicinsk indretning
DK3445344T3 (da) Nikotinadministrationsprodukt, relaterede anvendelser og orale doseringsformer, samt fremgangsmåder til fremstilling
DK3432887T3 (da) Anti-tuberkulosemiddel